ArticleCureus2025

A Comparative Evaluation of the Effects of Saroglitazar and Pioglitazone on Hepatic and Metabolic Parameters in Type 2 Diabetes Mellitus With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Dayanidhi Meher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.